The addiction liability of methadon (amidone, dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome.
about
Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysisThe methadone clinic: function and philosophy.Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data.Morphine enhances HIV infection of neonatal macrophages.Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivityDesign, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligandsMaintenance medication for opiate addiction: the foundation of recovery.Management of the oral surgery patient with drug dependence. II.Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances.Pharmacologic interventions for the treatment of opioid dependence and withdrawal.The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.Pain Management of Patients with Substance Abuse in the Ambulatory Setting.Factors associated with illicit opioid use in methadone maintenance treatment clients in 5 Provinces, China.Recent developments in chemotherapy of narcotic addiction. Part VI. LAAM and narcotic antagonists: introductory remarks.Extended-release formulation of morphine for subcutaneous administration.The effects of acute and chronic steady state methadone on memory retrieval in rats.Laeve-[1-3H]Methadone disposition in tolerant dogs.Adolescents and short term, low dose methadone maintenance.Commentary on the Second National Conference on Methadone Treatment.
P2860
Q28087193-5D7F7463-DC32-4630-98B6-5B0BA4B18379Q30432640-3B1AF065-2CE1-494C-B208-B790C1FEA16EQ33241229-44C42C68-0DA8-4EF8-AEE4-1FFE27CF7BE5Q33669599-4E312BC4-302A-4A97-A173-5304CC48AABCQ35216655-6CF04544-847B-49C0-80D2-8D34DF1579A2Q35236118-D9614B88-12CB-41F7-9D6F-696E9F7E8512Q36138164-AFAD8632-E828-4409-9961-16E1374EE1CBQ36838321-FAD20280-DCA7-4C8E-8EFF-E8C14EF408D8Q36880808-74712B40-A143-4649-A441-6C9CE4BE9F58Q37942997-895851D2-74E1-4C40-BD12-89F6487B5126Q38379235-3B59C79E-457A-4C8B-9496-C4EFB49D02FAQ38751647-BA7D0C9A-867F-41F9-9A1E-2DDEA9E56A69Q39325514-F54D92B5-210E-4812-851E-903EE50D8302Q40579753-83E9972B-1B67-4308-B058-465AC55B6BBCQ46055405-E6A47A3C-ECF5-4B2D-BEC5-2DC2A7EA8347Q48015170-BE538866-885D-49FE-903A-D5CEE3605F1DQ48466516-A5DF61D8-B63A-42E5-A32E-21F4254BA72CQ53719280-EA1D3FAF-19E6-4568-A615-884B7489496AQ54061184-F768E7B0-E2DD-426F-925B-C673655B269C
P2860
The addiction liability of methadon (amidone, dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome.
description
1949 nî lūn-bûn
@nan
1949 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1949 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1949年の論文
@ja
1949年論文
@yue
1949年論文
@zh-hant
1949年論文
@zh-hk
1949年論文
@zh-mo
1949年論文
@zh-tw
1949年论文
@wuu
name
The addiction liability of met ...... morphine abstinence syndrome.
@ast
The addiction liability of met ...... morphine abstinence syndrome.
@en
The addiction liability of met ...... morphine abstinence syndrome.
@nl
type
label
The addiction liability of met ...... morphine abstinence syndrome.
@ast
The addiction liability of met ...... morphine abstinence syndrome.
@en
The addiction liability of met ...... morphine abstinence syndrome.
@nl
prefLabel
The addiction liability of met ...... morphine abstinence syndrome.
@ast
The addiction liability of met ...... morphine abstinence syndrome.
@en
The addiction liability of met ...... morphine abstinence syndrome.
@nl
P356
P1476
The addiction liability of met ...... morphine abstinence syndrome.
@en
P2093
P304
P356
10.1176/AJP.105.12.909
P407
P577
1949-06-01T00:00:00Z